Kenneth Winton
Emergency Medicine · Crane, TXNPI 1922085521
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 236 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Lilly USA, LLC at 24.3% of the total. Reporting peaked in 2021 at $1,226 and has fallen 54.4% since, to $559 in 2023. Among emergency medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 236 payments — averaging $17.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$994
- Boehringer Ingelheim$487
- Amarin Pharma, Inc.$325
- AbbVie$315
- Novo Nordisk$283
- AstraZeneca$247
- plus $1K from 17 others
What the payments were for
- Food & beverage$4,083100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 62 | $994 |
| Boehringer Ingelheim | 27 | $487 |
| Amarin Pharma, Inc. | 19 | $325 |
| AbbVie(2 entities) | 11 | $315 |
| Novo Nordisk | 18 | $283 |
| AstraZeneca | 15 | $247 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $196 |
| Zyla Life Sciences, Inc. | 16 | $190 |
| Arbor Pharmaceuticals, Inc. | 12 | $187 |
| GSK | 7 | $165 |
| Merck | 9 | $141 |
| Biohaven Pharmaceuticals, Inc. | 6 | $121 |
| Eisai Inc. | 7 | $114 |
| Abbott | 3 | $63 |
| Redhill Biopharma Inc. | 3 | $55 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $46 |
| Shire North American Group Inc | 2 | $39 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| Assertio Therapeutics, Inc. | 2 | $22 |
| Pfizer | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $12 |
How this compares
$4,094 in reported general payments places this provider in the 95th percentile of 3,952 emergency medicine providers in Texas.
Other emergency medicine in Crane
- John McKinneyTyler$1.9M
- William PeacockHouston$513K
- Myiesha TaylorSunnyvale$369K
- James WilliamsSan Antonio$360K
- Armando MolinaEl Paso$290K
- Arthur AbelloAustin$204K
- Farid DharamsiDallas$159K
- David RobinsonHouston$143K
- Basil KhalafHouston$93K
- Elizabeth FaganMcKinney$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.